Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty

Hip replacement surgery is one of the most commonly performed surgical procedures in France, with approximately 150,000 procedures per year. Postoperative recovery has significantly improved in recent years, enabling faster rehabilitation. Although generally considered moderately painful, hip replacement surgery can, in some difficult-to-predict cases, lead to severe postoperative pain, requiring high doses of morphine, which may cause side effects and delay recovery. In other surgical procedures, regional anesthesia (nerve blocks) has been successfully used for pain relief. However, its effectiveness after hip replacement surgery has not yet been fully proven. A recent regional anesthesia technique-the Supra-Inguinal Fascia Iliaca Block (SIFIB)-which numbs a significant portion of the nerves around the hip, has recently been developed. When performed in all patients undergoing hip arthroplasty, the benefit of this technique could not be demonstrated. In addition, this technique may lead to transcient muscle blockade, wich also can delay recovery. In order to limit the use of nerve blocks to painful patients, we designed this study where the nerve block is performed only in patients experiencing significant paint after surgery. In conclusion, this study aims to assess the benefits of performing a rescue SIFIB in the recovery room for patients who experience significant postoperative pain after hip replacement surgery. The evaluation will focus on pain relief and ability to walk. No new treatment is being tested. The technique uses a commonly administered local anesthetic to numb the nerves.

Participants needed: 310
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Institut Mutualiste MontsourisUpdated: Sep 25, 2025Locations: 1
Eligibility criteria

patient scheduled for a primary total hip arthroplasty under general anesthesia, [+3]

per-operative complication making wheight-bearing and walking contra-indicated. [+1]

Status: Not yet recruiting

Focal Therapy in Localized Prostate Cancer: a Prospective Registry

The principal aim of the registry is to collect data on focal therapy (FT) for the treatment of intermediate-risk prostate cancer across Europe. Data will be gathered on cancer absence following treatment, survival rates, and the absence of disease failure or progression. Information will be collected from as many centers as possible over the next 5 years to enhance understanding of when focal therapy should be used, which energy types are most effective, and how patients respond to treatment, including its side effects and impact on quality of life. This Europe-wide data collection will contribute to improving care by informing the development of enhanced national and international guidelines for prostate cancer treatment with focal therapy.

Participants needed: 1,000
Trial details
Biological sex: MaleType: ObservationalSponsor: Institut Mutualiste MontsourisUpdated: Jan 13, 2025Duration: 5 Years
Eligibility criteria

Patients with intermediate risk PCa based on EAU risk groups with life expectanc... [+4]

Patients with intermediate risk treated with focal therapy without a previous ta... [+11]

Status: Recruiting

Comparison of 3 RF Delivery Modes of the QDOT Catheter for Paroxymal Atrial Fibrillation (AF) Ablation

Pulmonary vein isolation is the main treatment of paroxysmal and persistent atrial fibrillation. The aim of our study is to prospectively compare the efficacy and safety of the 3 options of radiofrequency delivery with QDOT Micro™, with systematic use of catheter stabilization tools and tighter lesions

Participants needed: 90
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Institut Mutualiste MontsourisUpdated: Oct 17, 2024Locations: 1
Eligibility criteria

Patient aged 18 or over [+5]

History of atrial fibrillation ablation (surgery or catheter) [+6]

Status: Recruiting

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors. Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors. Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Institut Mutualiste MontsourisUpdated: Apr 5, 2023Locations: 1
Eligibility criteria

all patient referred to the cardio oncology unit for suspected immune related ca...

none